To systematically assess and compare the prevalence of TF expression in solid tumors, IHC analysis using validated reagents and methods was performed on tumor tissue and TMAs that included specimens of a broad range of solid cancer types including gynecological, urological, breast, gastrointestinal, head and neck, non‐small cell lung, and glioblastoma. This evidence concerns the gene TF and neoplasm.